查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球运动医学市场 - 2023-2030 年
市场调查报告书
商品编码
1316301

全球运动医学市场 - 2023-2030 年

Global Sports Medicine Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概述

2022 年，全球运动医学市场规模达到 70 亿美元，预计到 2030 年将实现利润丰厚的增长，达到 113 亿美元。在预测期内（2023-2030 年），全球运动医学市场的复合年增长率预计将达到 6.3%。

运动损伤数量的增加、产品发布的增加、新疗法的推出、再生医学的进步以及对微创手术需求的增加等因素有望在预测期内推动全球运动医学市场的增长。

市场动态

市场发展推动运动医学市场增长

据估计，不断增长的市场发展将在预测期内推动全球运动医学市场的增长。例如，2023 年 3 月，医疗技术公司 Smith+Nephew 推出了 UltraTRAC QUAD ACL 重建技术，包括新型 QUADTRAC 股四头肌肌腱采集引导系统、X-WING 移植物准备系统和 ULTRABUTTON 可调固定装置系列。

同样，在 2022 年 7 月于科罗拉多斯普林斯举行的 2022 年美国运动医学矫形外科学会（AOSSM）年会上，全球医疗技术公司 Smith+Nephew 也推出了强大的阵容，其中包括几项精良的关节修复解决方案和一系列广泛的教育活动。

不断进步的技术有望为全球运动医学市场带来增长机会

与日俱增的进步为全球运动医学市场带来了利润丰厚的增长机会。例如，2023 年 6 月，Aspetar、骨科和运动医学医院推出了冲击波疗法，使其站在了运动医学的最前沿。

利用这一尖端技术，这种最先进的治疗方式正在改变组织的恢复和运动相关损伤的疼痛减轻，对运动员和个人产生了深远的影响。

严格监管机构的存在预计将在预测期内阻碍全球运动医学市场的发展

新开发的运动医学药物在审批方面存在严格的监管机构，这阻碍了预测期内全球市场的增长。例如，监督运动医学授权和商业化的主要监管机构包括美国食品药品管理局（USFDA）和欧洲药品管理局（欧盟负责评估和监督欧盟药品的机构）。

COVID-19 影响分析

COVID-19 在全球许多国家的流行和封锁影响了各行业公司的财务健康。因此，在 COVID-19 公共卫生紧急状态期间，美国食品和药物管理局 (FDA) 发布了指导方针，其中包括帮助申办者和研究人员的一般注意事项，以确保试验参与者的安全，遵守良好临床实践 (GCP)，并将试验完整性的风险降至最低。

俄乌战争影响分析

俄乌冲突被认为对全球运动医学市场的影响不大，因为该地区运动损伤的发生率较低，而且缺乏主要的市场参与者。乌克兰诊所虽然继续忍受俄罗斯军队的入侵，但迫于死亡人数不断增加和医疗援助有限的压力。所有药品都出现短缺。同样，基础材料进出口的重要性预计将在预测期内对全球运动医学市场的增长产生轻微影响。

目 录

第 1 章：研究方法与范围

  • 研究方法
  • 报告的研究目标和范围

第2章：定义和概述

第3章：执行摘要

  • 按产品分類的片段
  • 按应用划分
  • 按最终用户分类
  • 按地区划分

第四章：动态

  • 影响因素
    • 驱动因素
      • 市场日益发展
      • 运动伤害事件日益增多
    • 制约因素
      • 严格的监管机构
    • 机会
      • 不断进步
    • 影响分析

第 5 章：行业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章：COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情况
    • COVID-19 期间的情景
    • COVID-19 后的情况
  • COVID-19 期间的定价动态
  • 供求关系
  • 大流行期间与市场相关的政府倡议
  • 制造商的战略倡议
  • 结论

第 7 章：按产品分类

  • 车身重建与修复
  • 身体支持和恢复
  • 身体监测和评估设备
  • 附件

第 8 章：按应用分类

  • 踝关节和足部损伤
  • 背部和脊椎损伤
  • 肘部和腕部损伤
  • 髋关节损伤
  • 其他

第9章：按最终用户分类

  • 医院
  • 专科诊所
  • 其他

第 10 章：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第 11 章 ：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 合併与收购分析

第十二章 ：公司简介

  • Arthrex Inc.
    • 公司概况
    • 产品组合和说明
    • 财务概况
    • 主要发展
  • CONMED Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Mueller Sports Medicine Inc.
  • Performance Health
  • Smith & Nephew
  • Stryker Corporation
  • Wright Medical Group
  • Zimmer Biomet Holdings Inc.

第 13 章 ：附录

简介目录
Product Code: MD843

Market Overview

The global sports medicine market reached US$ 7.0 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 11.3 billion by 2030. The global sports medicine market is expected to exhibit a CAGR of 6.3% during the forecast period (2023-2030).

The increase in the number of sports injuries, rising product launches, introductions of new therapies, advancements in regenerative medicine, and increasing requirements for minimally invasive surgery are among the factors expected to boost the global sports medicine market growth in the forecast period.

Market Dynamics

Increasing Market Developments Drive The Growth of the Sports Medicine Market

The increasing market developments are estimated to boost the global sports medicine market growth in the forecast period. For instnace, in March 2023, Smith+Nephew, medical technology corporation, launched the UltraTRAC QUAD ACL Reconstruction Technique comprising of the new QUADTRAC Quadriceps Tendon Harvest Guide System, X-WING Graft Preparation System and family of ULTRABUTTON Adjustable Fixation Devices.

Likewise, in July 2022, Smith+Nephew, the global medical technology corpoLikewisentroduced a potent line-up featuring a few of its refined joint repair solutions and a wide collection of educational actions in the 2022 American Orthopaedic Society for Sports Medicine (AOSSM) Annual Meeting being held in Colorado Springs.

The Increase Advancements are Expected to Present the Global Sports Medicine Market With Growth Opportunities

The increasing advancements are presenting the global sports medicine market with lucrative growth opportunities. For instnace, in June 2023, Aspetar, Orthopaedic, and Sports Medicine Hospital introduced its Shockwave Therapy putting it at the forefront of sports medicine.

Employing this cutting-edge technology, this state-of-the-art therapy modality is altering tissue restoration and pain drop-in sports-associated injuries, making an influential impact on athletes and individuals.

The Presence of Stringent Regulatory Bodies is Estimated to Hamper the Global Sports Medicine Market During The Forecast Period

The presence of stringent regulatory bodies for the approval of newly developed drugs for sports medicine is hampering the global market growth in the forecast period. For instnace, the major regulatory bodies supervising the authorization and commercialization of sports medicine include the United States Food and Drug Administration (USFDA) and the European Medicines Agency, an agency of the European Union in charge of the evaluation and supervision of pharmaceutical products in the European Union.

COVID-19 Impact Analysis

The financial health of companies across all industries has been impacted by the COVID-19 pandemic and lockdown in numerous nations throughout the world. Therefore, for the period of the COVID-19 public health emergency, the U.S. Food and Drug Administration (FDA) issued guidelines that include general considerations to aid sponsors and researchers, ensuring the safety of trial participants, adhering to good clinical practice (GCP), and minimizing risks to trial integrity.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is thought to hold a moderate influence on the global sports medicine market, as there is a low incidence of sports injuries and a lack of primary market players in this region. Though continuing to countenance invasions from Russian armies, Ukrainian clinics are forced by growing numbers of deaths and limited medical aid. There are shortages across all Products of medications. Again, the significance of the import and export of fundamental materials are expected to slightly impact the global sports medicine market growth in the forecast period.

Segment Analysis

The global sports medicine market is segmented based on product, application, end-user, and region.

The Ankle & Foot Injuries Application is Estimated to Dominate the Global Sports Medicine Market

Owing to the increasing product introduction for the foot and ankle sports-injury applications segment into the global sports medicine market, the segment is estimated to hold a large share of the global market accounting for about 43.9%. For instance, in June 2022, Mueller Sports Medicine, an industry leader in sports medicine for the last six decades, launched its SKY Ankle Stabilizer.

As ankle sprains are the No.1 sports injury, SKY Stabilizer strives to deliver fit ankles and avert chronic ankle instability. It was developed for participants interested in vertical jumping sports such as basketball and volleyball as Mueller concentrated on simple elements of inversion sprains and biomechanics.

Geographical Analysis

Europe is Estimated to Hold 27.6% of the Market Share Owing to the Growing Cases of Chronic Conditions in this Region

Owing to the increasing incidences of sports injury in this region the European sports medicine market is estimated to hold around 27.6% of the global market share by 2030. For instance, in September 2022, London - Howden, the international insurance vendor, reported its European Football Injury Index for the 2021/2022 season for the guys' tournament, which demonstrates that injury expenses for the mainland's leading leagues broke via the half-a-billion-pound spot for the very foremost term (£513.23m/€610.75m). The whole number of injuries sustained throughout Europe's top five clubs was around 4,810 over the course of the previous season denoting a 20% boost in the 2020/2021 season.

Competitive Landscape

The major global players in the sports medicine market include: Arthrex Inc., CONMED Corporation, Johnson & Johnson, Medtronic PLC, Mueller Sports Medicine Inc., Performance Health, Smith & Nephew, Stryker Corporation, Wright Medical Group, Zimmer Biomet Holdings Inc. among others.

Why Purchase the Report?

  • To visualize the global sports medicine market segmentation based on product, application, end-user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of sports medicine market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available in Excel consisting of key products of all the major players.

The global sports medicine market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Market Developments
      • 4.1.1.2. Growing Incidences of Sports Injuries
    • 4.1.2. Restraints
      • 4.1.2.1. Stringent Regulatory Authorities
    • 4.1.3. Opportunity
      • 4.1.3.1. Increasing Advancements
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Body Reconstruction and Repair *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Body Support and Recovery
  • 7.4. Body Monitoring and Evaluation Devices
  • 7.5. Accessories

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Ankle & Foot Injuries*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Back & Spine Injuries
  • 8.4. Elbow & Wrist Injuries
  • 8.5. Hip Injuries
  • 8.6. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Other

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Spain
      • 10.3.6.5. Italy
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Arthrex Inc.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. CONMED Corporation
  • 12.3. Johnson & Johnson
  • 12.4. Medtronic PLC
  • 12.5. Mueller Sports Medicine Inc.
  • 12.6. Performance Health
  • 12.7. Smith & Nephew
  • 12.8. Stryker Corporation
  • 12.9. Wright Medical Group
  • 12.10. Zimmer Biomet Holdings Inc.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us